
| 2019 | |
|---|---|
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Total Project Funding per Partner: | 800-900 |
| Total Number of Projects: | > 1000 |
Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*
| Total project funding [€]: | Projects [No]: | |||||
|---|---|---|---|---|---|---|
| Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
| 2021 | 0 | 22.927.769 | 598.713 | 1 | ||
| 2019 | 0 | 13.999.998 | 1.990.000 | 1 | ||
Total number of partners: 65
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 65
Frequent / Rare Partner Ratio: 0
| Start date | Project | acronym | role | funding | partners |
|---|---|---|---|---|---|
| 2021-06-01 | RISK assessment of chemicals integrating HUman centric Next generation Testing strategies promoting the 3Rs | RISK-HUNT3R | participant | 22.927.769 | 38 |
| 2019-02-01 | Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease | TransBioLine | participant | 13.999.998 | 29 |